Danielle N. Margalit MD
Head & Neck
Associate Professor of Radiation Oncology, Harvard Medical School Staff Physician, Dana-Farber Cancer Institute and Brigham and Women's Hospital
Join to view full profile
100 Blossom StBoston, MA 02114
Phone+1 617-724-0288
Dr. Margalit is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2006 - 2010
- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2006
Certifications & Licensure
ME State Medical License 2020 - 2027
MA State Medical License 2008 - 2026
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2017
Clinical Trials
Publications & Presentations
PubMed
- US-based Delphi Consensus Study on Adjuvant Radiation Therapy (ART) in Node-Negative Cutaneous Squamous Cell Carcinoma (CSCC).Jacqueline S Stevens, Christopher A Barker, Richard L Bakst, Carol Bradford, David R Carr
International Journal of Radiation Oncology, Biology, Physics. 2026-10-16 - Response to Wang et al., "Time as a Substantial Confounder in Evaluating Integrated Multidisciplinary Care for Advanced Cutaneous Squamous Cell Carcinoma".Nina A Ran, Monika Bapna, Haley Neff, Abigail Waldman, Justine V Cohen
Journal of the American Academy of Dermatology. 2026-10-01 - Phase 1 trial and biomarker analysis of Buparlisib with weekly Cisplatin and Radiotherapy in high risk locally advanced squamous cell cancer of the Head and Neck.Jochen H Lorch, Kristine Wong, Roy B Tishler, Robert I Haddad, Anne O'Neill
Clinical Cancer Research. 2026-09-09
Press Mentions
Study Finds Standard Chemoradiation Therapy Superior to Deintensification Approaches for HPV-Related Oropharyngeal CancerApril 1st, 2025- Trial “Informs Practice Tremendously” for Low-Risk HPV-Oropharyngeal CancerOctober 8th, 2024
- Standard Chemoradiation Remains Superior for HPV-Associated Oropharyngeal CancerOctober 4th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: